Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
Alistair Vickery, Sebastian Roth, Tracie Ernenwein, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0272241-e0272241
Open Access | Times Cited: 21

Showing 21 citing articles:

Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials
Haron M. Jeddi, Jason W. Busse, Behnam Sadeghirad, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e068182-e068182
Open Access | Times Cited: 11
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
Elizabeth A. Cairns, Melissa J. Benson, Miguel A. Bedoya‐Pérez, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis: Real-world evidence from Project Twenty21
Michael T. Lynskey, Anne Katrin Schlag, Alkyoni Athanasiou‐Fragkouli, et al.
Drug Science Policy and Law (2023) Vol. 9
Open Access | Times Cited: 11
The driving‐related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation
Danielle McCartney, Cilla Zhou, Isobel Lavender, et al.
Drug and Alcohol Review (2025)
Open Access
Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: The QUEST Initiative 12-month follow-up observational study
Margaret-Ann Tait, Daniel Costa, Rachel Campbell, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320756-e0320756
Open Access
‘The wild west of medicine’: A qualitative investigation of the factors influencing Australian health‐care practitioners' delivery of medicinal cannabis
Olivia Dobson, Michaela Barber, Myfanwy Graham, et al.
Drug and Alcohol Review (2024) Vol. 43, Iss. 5, pp. 1280-1293
Open Access | Times Cited: 3
Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts
Gérard Mick, Pascal Douek
Pain and Therapy (2024) Vol. 13, Iss. 5, pp. 1063-1094
Open Access | Times Cited: 3
Cannabis for endometriosis‐related pain and symptoms: It's high time that we see this as a legitimate treatment
Mike Armour, Justin Sinclair
Australian and New Zealand Journal of Obstetrics and Gynaecology (2023) Vol. 63, Iss. 1, pp. 118-120
Closed Access | Times Cited: 7
Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry
Ann Francis, Simon Erridge, Carl Holvey, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2024) Vol. 38, Iss. 2, pp. 103-116
Open Access | Times Cited: 2
Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal Study
Andreas Halman, Richard Chenhall, Daniel Perkins
Journal of Pain & Palliative Care Pharmacotherapy (2024), pp. 1-13
Open Access | Times Cited: 2
Preliminary findings from project Twenty21 Australia: An observational study of patients prescribed medicinal Cannabis for chronic pain, anxiety, posttraumatic stress disorder and multiple sclerosis
Kylie O’Brien, Justin Beilby, Michelle Frans, et al.
Drug Science Policy and Law (2023) Vol. 9
Closed Access | Times Cited: 4
Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications
Hannah Thurgur, Anne Katrin Schlag, Elizabeth Iveson, et al.
Exploration of Medicine (2023), pp. 487-503
Open Access | Times Cited: 4
Cross-national reflections on medicinal cannabis and depression
Vania Modesto‐Lowe, Roberto León-Barriera, Lakshit Jain
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 5, pp. 479-480
Open Access | Times Cited: 2
An overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: A scoping review using a systematic approach
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Joint Effects: Where and How the Frequency of Cannabis Use Shapes the Relationship Between Employee Mental Health and Sickness Absenteeism
Caroline Jordan Moughan, Ian M. Katz
Occupational Health Science (2024)
Closed Access
Characterization of Cannabis users and products and the experience of negative mental emotions following Cannabis use
Nir Treves, Noa Yakirevich-Amir, Wiessam Abu Ahmad, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access
Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
BMJ Open (2024) Vol. 14, Iss. 7, pp. e085166-e085166
Open Access
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
Michael T. Lynskey, Hannah Thurgur, Alkyoni Athanasiou‐Fragkouli, et al.
Archives of Suicide Research (2024), pp. 1-15
Closed Access
Medical Cannabis Dosing Trajectories of Patients: Evidence From Sales Data
Alexandra F. Kritikos, Myfanwy Graham, Dominic Hodgkin, et al.
Clinical Therapeutics (2024)
Closed Access
NSW cannabis medicines advisory service retrospective enquiry analysis to inform clinical guidance resource development
Myfanwy Graham, Edward Eden, Kelsey Maddison, et al.
Neuropsychopharmacology Reports (2024)
Open Access
Page 1

Scroll to top